Progeny from irradiated colorectal cancer cells acquire an EMT-like phenotype and activate wnt/β-catenin pathway

Journal of Cellular Biochemistry

Volumn 115, Issue 12, 2014, Pages 2175-2187

  Bastos, Lilian Gonçalves Dos Reis ^a   De Marcondes, Priscila Guimarães ^a   De Freitas Junior, Julio Cesar Madureira ^a   Leve, Fernanda ^b   Mencalha, André Luiz ^c   De Souza, Waldemir Fernandes ^a   De Araujo, Wallace Martins ^a   Tanaka, Marcelo Neves ^d   Abdelhay, Eliana Saul Furquim Werneck ^a   Morgado Díaz, José André ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d CENTRO BRASILEIRO DE PESQUISAS FÍSICAS   (Brazil)

Author keywords

COLORECTAL CANCER; EMT; RADIORESISTANCE; Wnt CATENIN PATHWAY

Indexed keywords

BETA CATENIN; CASPASE; MESSENGER RNA; METALLOPROTEINASE; SURVIVIN; UVOMORULIN; VIMENTIN; WNT PROTEIN; BIRC5 PROTEIN, HUMAN; CADHERIN; CDH1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

ACTIN FILAMENT; ARTICLE; BETA CATENIN SIGNALING PATHWAY; CANCER CELL; CELL ADHESION; CELL MIGRATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLONOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IRRADIATION; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; WNT SIGNALING PATHWAY; APOPTOSIS; CACO 2 CELL LINE; CELL MOTION; CELL SHAPE; COLORECTAL TUMOR; HT 29 CELL LINE; METABOLISM; RADIATION DOSE; RADIATION RESPONSE;

ACTIN CYTOSKELETON; APOPTOSIS; BETA CATENIN; CACO-2 CELLS; CADHERINS; CASPASES; CELL MOVEMENT; CELL SHAPE; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; HT29 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM INVASIVENESS; RADIATION TOLERANCE; VIMENTIN; WNT SIGNALING PATHWAY;

EID: 84927142931     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24896     Document Type: Article

References (50)

1. Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknæs M, Hektoen M, Lind GE, Lothe RA,. 2013. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2: e71.
2. Alexander S, Friedl P,. 2012. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. Trends Mol Med 18: 13-26.
3. Andarawewa KL, Costes SV, Fernandez-Garcia I, Chou WS, Ravani SA, Park H, Barcellos-Hoff MH,. 2011. Lack of radiation dose or quality dependence of epithelial-to-mesenchymal transition (EMT) mediated by transforming growth factor β. Int J Radiat Oncol Biol Phys 79: 1523-1531.
4. Andarawewa KL, Erickson AC, Chou WS, Costes SV, Gascard P, Mott JD, Bissell MJ, Barcellos-Hoff MH,. 2007. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res 67: 8662-8670.
5. Aurelio ON, Kong XT, Gupta S, Stanbridge EJ,. 2000. P53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines. Mol Cell Biol 20: 770-778.
6. Barcellos-Hoff MH, Park C, Wright EG,. 2005. Radiation and the microenvironment-tumorigenesis and therapy. Nat Rev Cancer 5: 867-875.
7. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O'Reilly MS,. 2001. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61: 2207-2211.
8. de Carvalho AD, de Souza W, Morgado-Díaz JA,. 2006. Morphological and molecular alterations at the junctional complex in irradiated human colon adenocarcinoma cells Caco-2. Int J Radiat Biol 82: 658-668.
9. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R,. 2003. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 159: 283-300.
10. Deryugina EI, Quigley JP,. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34.
11. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad Ø,. 2004. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 40: 1593-1598.
12. Fodde R, Brabletz T,. 2007. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158.
13. Friedl P, Locker J, Sahai E, Segall JE,. 2012. Classifying collective cancer cell invasion. Nat Cell Biol 14: 777-783.
14. Hanahan D, Weinberg RA,. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
15. Harada H, Inoue M, Itasaka S, Hirota K, Morinibu A, Shinomiya K, Zeng L, Ou G, Zhu Y, Yoshimura M, McKenna WG, Muschel RJ, Hiraoka M,. 2012. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels. Nat Commun 3: 783.
16. Herszényi L, Hritz I, Lakatos G, Varga MZ, Tulassay Z,. 2012. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Int J Mol Sci 13: 13240-13263.
17. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. 2011. Global cancer statistics. CA Cancer J Clin 61: 69-90.
18. Jung JW, Hwang SY, Hwang JS, Oh ES, Park S, Han IO,. 2007. Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells. Eur J Cancer 43: 1214-1224.
19. Kim JJ, Tannock IF,. 2005. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5: 516-525.
20. Kopito RR,. 2000. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10: 524-530.
21. Krieg A, Werner TA, Verde PE, Stoecklein NH, Knoefel WT,. 2013. Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis. PLoS ONE 8 (6): e65338.
22. Kumar A, Collins HM, Scholefield JH, Watson SA,. 2000. Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer. Br J Cancer 82: 960-965.
23. Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q, Wang Y, Lai YJ, LaBaff AM, Wu TJ, Lin BR, Yang MH, Hortobagyi GN, Hung MC,. 2012. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1. Cancer Res 72: 1290-1300.
24. Li T, Zeng ZC, Wang L, Qiu SJ, Zhou JW, Zhi XT, Yu HH, Tang ZY,. 2011. Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition. Cancer Gene Ther 18: 617-626.
25. Lund N, Henrion D, Tiede P, Ziche M, Schunkert H, Ito WD,. 2010. Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation. Biochem Biophys Res Commun 395: 401-406.
26. Luo J,. 2009. Glycogen synthase kinase 3β (GSK3-β) in tumorigenesis and cancer chemotherapy. Cancer Lett 273: 194-200.
27. Lõpez I, P Oliveira L, Tucci P, Alvarez-Valín F, A Coudry R, Marín M,. 2012. Different mutation profiles associated to P53 accumulation in colorectal cancer. Gene 499: 81-87.
28. Ministério da Saúde,. 2011. Estimativa 2012: incidência de câncer no Brasil. Brazil: Rio de Janeiro.
29. Mita AC, Mita MM, Nawrocki ST, Giles FJ,. 2008. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14: 5000-5005.
30. Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R,. 2012. Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol 25: 1315-1325.
31. Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T,. 2012. Randomized clinical trial on preoperative radiotherapy 25Gy in rectal cancer-treatment results at 5-year follow-up. Langenbecks Arch Surg 397: 801-807.
32. Palacios F, Tushir JS, Fujita Y, D'Souza-Schorey C,. 2005. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 25: 389-402.
33. Peinado H, Olmeda D, Cano A,. 2007. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype. Nat Rev Cancer 7: 415-428.
34. Petrie RJ, Doyle AD, Yamada KM,. 2009. Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10: 538-549.
35. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, Papadopoulou A, Bicknell D, Bodmer WF, Tomlinson IP,. 2000. APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits." Proc Natl Acad Sci USA 97: 3352-3357.
36. Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C,. 2008. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11: 123-151.
37. Sah NK, Khan Z, Khan GJ, Bisen PS,. 2006. Structural, functional and therapeutic biology of survivin. Cancer Lett 244: 164-171.
38. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M,. 2009. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373: 811-820.
39. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E,. 2012. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62: 220-241.
40. Stauber RH, Mann W, Knauer SK,. 2007. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67: 5999-6002.
41. Thiery JP, Acloque H, Huang RY, Nieto MA,. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
42. Tojkander S, Gateva G, Schevzov G, Hotulainen P, Naumanen P, Martin C, Gunning PW, Lappalainen P,. 2011. A molecular pathway for myosin II recruitment to stress fibers. Curr Biol 21: 539-550.
43. Tsukamoto H, Shibata K, Kajiyama H, Terauchi M, Nawa A, Kikkawa F,. 2007. Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells. Gynecol Oncol 107: 500-504.
44. van den Brink M, Stiggelbout AM, van den Hout WB, Kievit J, Klein Kranenbarg E, Marijnen CA, Nagtegaal ID, Rutten HJ, Wiggers T, van de Velde CJ,. 2004. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 22: 3958-3964.
45. Verkaar F, Zaman GJ,. 2011. New avenues to target Wnt/β-catenin signaling. Drug Discov Today 16: 35-41.
46. Wei J, Xu G, Wu M, Zhang Y, Li Q, Liu P, Zhu T, Song A, Zhao L, Han Z, Chen G, Wang S, Meng L, Zhou J, Lu Y, Ma D,. 2008. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res 28: 327-334.
47. Wong RK, Berry S, Spithoff K, Simunovic M, Chan K, Agboola O, Dingle B, Group GCDS,. 2010. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol) 22: 265-271.
48. Workman P, Al-Lazikani B, Clarke PA,. 2013. Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology. Curr Opin Pharmacol 13: 486-496.
49. Wu B, Crampton SP, Hughes CCW,. 2007. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26: 227-239.
50. Yamaguchi H, Condeelis J,. 2007. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773: 642-652.